Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD99 antibody (C-Term)

This anti-CD99 antibody is a Rabbit Monoclonal antibody detecting CD99 in IHC (f). Suitable for Human.
Catalog No. ABIN7126690

Quick Overview for Recombinant CD99 antibody (C-Term) (ABIN7126690)

Target

See all CD99 Antibodies
CD99

Antibody Type

Recombinant Antibody

Reactivity

  • 141
  • 26
  • 10
  • 6
  • 1
  • 1
Human

Host

  • 94
  • 70
  • 4
Rabbit

Clonality

  • 97
  • 71
Monoclonal

Conjugate

  • 68
  • 11
  • 11
  • 10
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD99 antibody is un-conjugated

Application

  • 66
  • 63
  • 60
  • 35
  • 26
  • 22
  • 22
  • 18
  • 14
  • 13
  • 13
  • 11
  • 5
  • 4
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Binding Specificity

    • 15
    • 6
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Specificity

    CD99 is a type I transmembrane glycoprotein encoded by the CD99 gene and the functions of CD99 in cells in which CD99 was highly expressed have been studied and they were as follows: cell death of thymocytes and T lymphocytes, migration through monocyte endothelial junctions by adhesion and diapedesis, cell-cell adhesion in lymphocytes, maintenance of cellular morphology in Hodgkin and Reed/Sternberg cells, and recruitment of T cells.CD99 expression has been reported in many cell types, such as hematopoietic cells, endothelial cells, central nervous system ependymal cells, thymocytes, granular cells of the ovary, Sertoli cells, and pancreatic islet cells. And in tumors it expressed by virtually almost all Ewing s sarcoma and primitive peripheral neuroectodermal tumors (ES/PNET) and demonstrates strong and diffuse membranous staining. Other tumors that may show CD99 expression include neuroendocrine carcinomas, mesenchymal chondrosarcomas, solitary fibrous tumors, synovial sarcomas, vascular tumors, small round blue cell tumors, lymphoblastic lymphoma, acute myeloid leukemia, and myeloid sarcoma. Studies have shown that CD99 may be a sensitive marker for Ewing s sarcoma and peripheral neuroectodermal tumors.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Synthetic peptide corresponding to CD99 residues within aa85 C terminal of CD99 was used as an immunogen.

    Isotype

    IgG
  • Application Notes

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: MOLT-4 cells. Pancreas or Ewing s sarcoma

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    CD99

    Alternative Name

    CD99

    Background

    12E7, E2 antigen, MIC 2X, MIC 2Y, MIC2, Protein MIC2, Surface antigen MIC2, T-cell surface glycoprotein E2,CD99 / MIC2 (Ewing s Sarcoma Marker)
    Cellular localisation: Cell Surface

    Molecular Weight

    19kDa

    Gene ID

    4267, 653349

    UniProt

    P14209
You are here:
Chat with us!